Search research articles
Contact Us
Filters
Showing results (261-270 of 321) with videos related to
Page
of 33
Sort By:
Der Radiologe
|
September 28, 2000
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]
T M Moehler, H Hawighorst, K Neben, et al.
Journal of Stem Cells & Regenerative Medicine
|
April 3, 2014
Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells
P Horn, G Bokermann, D Cholewa, et al.
Seminars in Oncology
|
December 1, 1993
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia
R Haas, A D Ho, F Del Valle, et al.
Annals of Hematology
|
March 22, 2002
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation
C Gemmel, F W Cremer, M Weis, et al.
Leukemia
|
April 18, 2002
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia
R F Schlenk, F Hartmann, M Hensel, et al.
Leukemia
|
September 1, 1990
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM)
W Hiddemann, T Büchner, G Heil, et al.
International Journal of Cancer
|
August 24, 2001
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging
T M Moehler, H Hawighorst, K Neben, et al.
Experimental Hematology
|
January 29, 1999
Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals
P Law, T A Lane, A Gervaix, et al.
Experimental Hematology
|
November 1, 1996
Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both
A D Ho, D Young, M Maruyama, et al.
Bone Marrow Transplantation
|
August 5, 2014
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
I Breitkreutz, C Heiss, A Perne, et al.
Page
of 33
Search research articles
Search
Showing results (261-270 of 321) with videos related to
Sort By:
Page
of 33
Der Radiologe
|
September 28, 2000
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]
T M Moehler, H Hawighorst, K Neben, et al.
Journal of Stem Cells & Regenerative Medicine
|
April 3, 2014
Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells
P Horn, G Bokermann, D Cholewa, et al.
Seminars in Oncology
|
December 1, 1993
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia
R Haas, A D Ho, F Del Valle, et al.
Annals of Hematology
|
March 22, 2002
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation
C Gemmel, F W Cremer, M Weis, et al.
Leukemia
|
April 18, 2002
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia
R F Schlenk, F Hartmann, M Hensel, et al.
Leukemia
|
September 1, 1990
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM)
W Hiddemann, T Büchner, G Heil, et al.
International Journal of Cancer
|
August 24, 2001
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging
T M Moehler, H Hawighorst, K Neben, et al.
Experimental Hematology
|
January 29, 1999
Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals
P Law, T A Lane, A Gervaix, et al.
Experimental Hematology
|
November 1, 1996
Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both
A D Ho, D Young, M Maruyama, et al.
Bone Marrow Transplantation
|
August 5, 2014
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
I Breitkreutz, C Heiss, A Perne, et al.
Page
of 33